THE Therapeutic Goods
Administration has designated
eculizumab (rmc) (SOLIRIS) as an
orphan drug.
Eculizumab is sponsored by
Alexion Pharmaceuticals and is
indicatedd for the treatment of
atypical haemolytic uraemic
syndrome (aHUS).The above article was sent to subscribers in Pharmacy Daily's issue from 21 Sep 12 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 21 Sep 12
DERMATOLOGY company Botanix Pharmaceuticals Limited has been officially included yesterday in the Australian Securities Exchange (ASX) All Ordinaries Index (All Ords).
RESEARCHERS at the University of South Australia have developed a new method for treating liver cancer, using 3D printed films that deliver chemotherapy drugs directly to the site of the tumour.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.